Advertisement

Related Videos

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Advertisement

Advertisement




Jan
06
Today In Oncology
Survey Finds Most People Trust AI Less Than Physicians, but See Its Potential for Cancer Diagnosis
AI-Based Imaging Model Predicts Extranodal Extension Burden and Improves Risk Stratification in Oropharyngeal Cancer
Preoperative PAXG vs mFOLFIRINOX in Pancreatic Ductal Adenocarcinoma
High Neighborhood Fast Food Expenditure and Early-Onset Colorectal Cancer
HCC Real-World Patterns of Systemic Therapy, Sequencing, and Survival
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo